Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-808.06%EBITDA Margin
VS
Market
Sector
Industry
History
$ 18.81Close
$ 7.38 - $ 61.57 52-Week Range
Ticker Information
Ticker
TNXPCompany Name
TONIX PHARMACEUTICALS HOLDING CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTONIX PHARMACEUTICALS HOLDING CORP - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TNXP - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -79.44M | -808.06% | $ 9.83M |
| 3/31/2025 | $ -129.22M | -1286.94% | $ 10.04M |
| 12/31/2024 | $ -126.61M | -1254.36% | $ 10.09M |
| 9/30/2024 | $ -131.06M | -1160.78% | $ 11.29M |
| 6/30/2024 | $ -144.12M | -1156.85% | $ 12.46M |
| 3/31/2024 | $ -93.98M | -916.92% | $ 10.25M |
| 12/31/2023 | $ -112.37M | -1446.54% | $ 7.77M |
| 9/30/2023 | $ -117.15M | -2936.83% | $ 3.99M |
| 6/30/2023 | $ -119.12M | 0% | $ 0 |
| 3/31/2023 | $ -114.72M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- TONIX PHARMACEUTICALS HOLDING CORP's latest trailing twelve months (TTM) EBITDA % stands at 0%.
- Over the past 5 years, TONIX PHARMACEUTICALS HOLDING CORP's average EBITDA % has been -1370.91%.
- The median EBITDA % for TONIX PHARMACEUTICALS HOLDING CORP during this period was -1207.57%
- TONIX PHARMACEUTICALS HOLDING CORP reached its highest EBITDA % over the past 5 years at -808.06%.
- The lowest EBITDA % recorded by TONIX PHARMACEUTICALS HOLDING CORP in the same timeframe -2936.83%
TONIX PHARMACEUTICALS HOLDING CORP's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for TONIX PHARMACEUTICALS HOLDING CORP is calculated as follows: EBITDA [ $ -42.12M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ] TNXP - EBITDA Margin, Last 5 years
-2936.83%
Minimum
Sep 30, 2023
-808.06%
Maximum
Jun 30, 2025
-1370.91%
Average
-1207.57%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |